Evidence map›Paper›PMID 22363814›Full record

ArticlePloS one2012

Insulin-like growth factors promote vasculogenesis in embryonic stem cells.

Stephanie M Piecewicz, Ambarish Pandey, Bhaskar Roy, Soh Hua Xiang, Bruce R Zetter, Shiladitya Sengupta

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Cells · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Essential role of theLife science alliance · 2020
    Article
  11. Article
  12. Frontiers in physiology · 2018
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. IGF-I Signaling in Osterix-Expressing Cells Regulates Secondary Ossification Center Formation, Growth Plate Maturation, and Metaphyseal Formation During Postnatal Bone Development.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Stephanie M PiecewiczDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America. stephanie.piecewicz@gmail.com
Ambarish Pandey
Bhaskar Roy
Soh Hua Xiang
Bruce R Zetter
Shiladitya Sengupta
Brigham and Women's Hospital · USBoston Children's Hospital · USHarvard–MIT Division of Health Sciences and Technology · USHarvard University · US

Funding

T32 Training Program in Mechanisms and Innovation in Vascular DiseaseT32HL098049 · NHLBI · STANFORD UNIVERSITY · PI Nicholas James Leeper, Philip S Tsao · 2010 to 2026
$6.3M
NHLBI NIH HHS T32 HL098049
6 · The paper itself

Abstract

The ability of embryonic stem cells to differentiate into endothelium and form functional blood vessels has been well established and can potentially be harnessed for therapeutic angiogenesis. However, after almost two decades of investigation in this field, limited knowledge exists for directing endothelial differentiation. A better understanding of the cellular mechanisms regulating vasculogenesis is required for the development of embryonic stem cell-based models and therapies. In this study, we elucidated the mechanistic role of insulin-like growth factors (IGF1 and 2) and IGF receptors (IGFR1 and 2) in endothelial differentiation using an embryonic stem cell embryoid body model. Both IGF1 or IGF2 predisposed embryonic stem to differentiate towards a mesodermal lineage, the endothelial precursor germ layer, as well as increased the generation of significantly more endothelial cells at later stages. Inhibition of IGFR1 signaling using neutralizing antibody or a pharmacological inhibitor, picropodophyllin, significantly reduced IGF-induced mesoderm and endothelial precursor cell formation. We confirmed that IGF-IGFR1 signaling stabilizes HIF1α and leads to up-regulation of VEGF during vasculogenesis in embryoid bodies. Understanding the mechanisms that are critical for vasculogenesis in various models will bring us one step closer to enabling cell based therapies for neovascularization.

Indexed as

AnimalsCarrier ProteinsCell DifferentiationEmbryoid BodiesEmbryonic Stem CellsEndotheliumExtracellular Signal-Regulated MAP KinasesHypoxia-Inducible Factor 1, alpha SubunitInsulin-Like Growth Factor IInsulin-Like Growth Factor IIMesodermMiceModels, BiologicalNeovascularization, PhysiologicPodophyllotoxinProtein StabilityCarrier ProteinsExtracellular Signal-Regulated MAP KinasesHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitInsulin-Like Growth Factor IInsulin-Like Growth Factor IIpicropodophyllinPodophyllotoxinProto-Oncogene Proteins c-aktReceptor, IGF Type 1Receptor, IGF Type 2Vascular Endothelial Growth Factor A

Identifiers

PMID22363814
PMCPMC3283730
OpenAlexW2076733365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.